|1.||Li, Guilan: 2 articles (09/2006 - 06/2003)|
|2.||Yin, Songnian: 2 articles (09/2006 - 06/2003)|
|3.||Waidyanatha, Suramya: 2 articles (02/2005 - 06/2003)|
|4.||Barnes, Martine L: 1 article (02/2005)|
|5.||Golding, Bernard T: 1 article (02/2005)|
|6.||Clegg, William: 1 article (02/2005)|
|7.||Heath, Sarah L: 1 article (02/2005)|
|8.||Cameron, Richard: 1 article (02/2005)|
|9.||Rappaport, Stephen M: 1 article (02/2005)|
|10.||Watson, William P: 1 article (02/2005)|
|1.||Chromosome Aberrations (Chromosome Abnormalities)
09/01/2006 - "Some of these are benzene oxide-protein adducts, chromosome aberration of lymphocytes, and GPA mutations in erythrocytes, a decrease in B cell and CD4(-)T cell counts in peripheral blood, and altered expression of CXCL16, ZNF331, JUN, and PF4 in lymphocytes. "
06/01/2003 - "The biomarkers evaluated were urinary metabolites S-phenylmercapturic acid (S-PMA*), trans,trans-muconic acid (t,t-MA), hydroquinone (HQ), catechol (CAT), and phenol; albumin adducts of benzene oxide and 1,4-benzoquinone (BO-Alb and 1,4-BQ-Alb, respectively) in blood; blood cell counts; and chromosomal aberrations. "
|2.||Body Weight (Weight, Body)
09/15/1994 - "administration of a mixture of [14C]- and [13C6]benzene between 50 and 400 mg/kg body weight, cysteine adducts of benzene oxide, 1,2-BQ, and 1,4-BQ were assayed, and the proportions of cysteine-bound adducts to total protein binding were estimated. "
03/01/2000 - "The stability of cysteinyl adducts of benzene oxide (BO) and mono-S-substituted cysteinyl adducts of 1,4-benzoquinone (1,4-BQ) was investigated in both hemoglobin (Hb) and albumin (Alb) following administration of a single oral dose of 400 mg [U-14C/13C6]benzene/kg body weight to F344 rats. "
|4.||Dehydration (Water Stress)
02/01/2005 - "Incubation of benzene oxide with N-acetyl-L-cysteine at 37 degrees C and pH 10.0 and subsequent mass spectrometric analysis of the mixture showed formation of pre-S-phenylmercapturic acid and the dehydration product, S-phenylmercapturic acid. "
02/01/2005 - "The reaction of intracellular glutathione with benzene oxide-oxepin, the initial metabolite of benzene, is presumed to give 1-(S-glutathionyl)-cyclohexa-3,5-dien-2-ol, which undergoes dehydration to S-phenylglutathione, the precursor of S-phenylmercapturic acid. "
|4.||Phenol (Carbolic Acid)
|5.||Biological Markers (Surrogate Marker)
|8.||Glutathione (Reduced Glutathione)
|10.||Carrier Proteins (Binding Protein)